• MGH health centers join in Health Day '99
  MGH Charlestown HealthCare Center and Boston Evening Medical Center recently participated in Health Day '99, a citywide effort to promote health education.

• MGHers recognized for blood donation
  More than 90 MGH employees recently were honored for their generosity to the MGH Blood Donor Center at a special appreciation luncheon Sept. 24.

• Shedding light on the darkness of depression
  Depression is an illness that affects body, mood, thoughts and behavior. Fortunately, the myriad doctors and researchers working on depression have developed better techniques and more improvements to existing treatments than ever before.

• Wage and salary program announced
  As the hospital continues to tighten its fiscal belt, the MGH this week announced a fiscal year 2000 wage and salary program that includes a performance-based wage and salary increase.

• MGH researchers identify angiogenesis inhibitor in gallbladder cancer
  An MGH research team has discovered that a cellular growth factor called TGFß1 has a previously unsuspected role in regulating the growth of blood vessels associated with metastatic gallbladder cancer.

• Anticipated cancer clinical trial begins in Boston
  Patient enrollment for a Phase I cancer clinical trial of Endostatin started Sept. 28 at the MGH, BWH and Dana-Farber Cancer Institute – members of Dana-Farber/Partners CancerCare (DFPCC) – in collaboration with Beth Israel Deaconess Medical Center.

• In General

• What's Happening

Hotline Home Page | Back Issues | News Releases | Public Affairs Home Page | MGH Home Page